Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
 

Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
SAN JOSE, Calif.,/NEW YORK (Reuters) – A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C.


http://rc.feedsportal.com/r/24739586...19/rc/1/rc.img

http://rc.feedsportal.com/r/24739586...19/rc/2/rc.img

http://rc.feedsportal.com/r/24739586...19/rc/3/rc.img


http://da.feedsportal.com/r/24739586...f/sc/19/a2.img
http://adchoice.feedsportal.com/r/24.../sc/19/ach.imghttp://pi.feedsportal.com/r/24739586.../sc/19/a2t.imghttp://pi2.feedsportal.com/r/2473958...sc/19/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Us:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Us:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/lQ-2-kvxB4o